Russ Altman, MD, PhD, Professor & Chair, Bioengineering, Stanford University, discusses the therapeutic advantages to be gained from integrating molecular, cellular, EMR and population data to understand how drugs work, alone and in combination.

Filmed at FutureMed, in February, 2012, at Singularity University.